Evidence map›Paper›PMID 35874779›Full record

ArticleFrontiers in immunology2022

Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable

Rika Nakahashi-Ouchida, Hiromi Mori, Yoshikazu Yuki, Shingo Umemoto, Takashi Hirano, Yohei Uchida, Tomonori Machita, Tomoyuki Yamanoue, Shin-Ichi Sawada, Masashi Suzuki and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Rika Nakahashi-OuchidaDivision of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Hiromi MoriDivision of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Yoshikazu YukiDivision of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Shingo UmemotoFaculty of Medicine, Department of Otorhinolaryngology, Head and Neck Surgery, Oita University, Oita, Japan.
Takashi HiranoFaculty of Medicine, Department of Otorhinolaryngology, Head and Neck Surgery, Oita University, Oita, Japan.
Yohei UchidaDivision of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Tomonori MachitaDivision of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Tomoyuki YamanoueDivision of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Shin-Ichi SawadaDepartment of Polymer Chemistry, Faculty of Engineering, Kyoto University, Kyoto, Japan.
Masashi SuzukiFaculty of Medicine, Department of Otorhinolaryngology, Head and Neck Surgery, Oita University, Oita, Japan.
Kohtaro FujihashiDepartment of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.
Kazunari AkiyoshiDepartment of Polymer Chemistry, Faculty of Engineering, Kyoto University, Kyoto, Japan.
Yuichi KuronoDepartment of Otolaryngology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.
Hiroshi KiyonoDivision of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Chiba University Hospital · JPThe University of Tokyo · JPKyoto University · JPOita University · JPChiba University · JPKagoshima University · JPUniversity of Alabama at Birmingham · USUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nontypeable

Indexed as

Haemophilus InfectionsHaemophilus VaccinesOtitis MediaAnimalsAntibodies, BacterialBacterial Outer Membrane ProteinsChildChild, PreschoolHaemophilus influenzaeHumansImmunoglobulin AMiceMice, Inbred BALB CNanogelsAntibodies, BacterialBacterial Outer Membrane ProteinsHaemophilus VaccinesImmunoglobulin ANanogelscCHP nanogeldrug delivery systemmucosal IgAnasal vaccinenontypeable Haemophilus influenzae

Identifiers

PMID35874779
PMCPMC9299436
OpenAlexW4286632596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.